Broadcast

The Science of Radiofrequency Renal Denervation

Stefan Tunev, Andrew SP Sharp

Watch time: 1h 12m 55s

Broadcast

Nocturnal Hypertension

Roland Asmar, , , et al

Watch time: 1h 9m 26s

About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Articles

The Role of Dihydropyridine Calcium Channel Blockers in the Treatment of Hypertension and Cardiovascular Disease - An Update

Citation:

European Cardiovascular Disease 2006;2(1):1–6

Pulmonary Arterial Hypertension in Connective Tissue Diseases - A Devastating Complication

Citation:

European Cardiovascular Disease 2007;3(2):69–73

Hypertension in Octogenarians - Treatment Strategies and Challenges

Citation:

European Cardiology 2011;7(1):25–8

Controlling Blood Pressure without Drugs - Developing New Strategies

Citation:

European Cardiology 2010;6(2):18–21